FRMD5
Basic information
Region (hg38): 15:43870760-44195271
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with eye movement abnormalities and ataxia (Moderate), mode of inheritance: AD
- neurodevelopmental disorder with eye movement abnormalities and ataxia (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with eye movement abnormalities and ataxia | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 36206744 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (18 variants)
- Neurodevelopmental disorder with eye movement abnormalities and ataxia (7 variants)
- not provided (4 variants)
- See cases (3 variants)
- not specified (2 variants)
- Neurodevelopmental delay (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FRMD5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 1 | |||||
Total | 0 | 1 | 25 | 1 | 3 |
Variants in FRMD5
This is a list of pathogenic ClinVar variants found in the FRMD5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-43873902-G-T | Inborn genetic diseases | Uncertain significance (Oct 17, 2023) | ||
15-43873911-C-G | Inborn genetic diseases | Uncertain significance (Mar 01, 2023) | ||
15-43873937-C-T | Inborn genetic diseases | Uncertain significance (Jul 06, 2021) | ||
15-43873961-T-C | Neurodevelopmental delay • Neurodevelopmental disorder with eye movement abnormalities and ataxia | Uncertain significance (Aug 19, 2022) | ||
15-43873985-G-T | Inborn genetic diseases | Uncertain significance (Mar 29, 2022) | ||
15-43874076-T-A | Inborn genetic diseases | Uncertain significance (Mar 05, 2024) | ||
15-43874090-C-T | Inborn genetic diseases | Uncertain significance (Jul 12, 2023) | ||
15-43874207-G-A | Inborn genetic diseases | Uncertain significance (Jul 14, 2022) | ||
15-43874219-T-A | Inborn genetic diseases | Uncertain significance (Jan 07, 2022) | ||
15-43874289-C-T | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
15-43874294-A-G | Inborn genetic diseases | Uncertain significance (Mar 29, 2023) | ||
15-43874304-G-A | Inborn genetic diseases | Uncertain significance (Sep 16, 2021) | ||
15-43874310-C-T | Inborn genetic diseases | Uncertain significance (Oct 05, 2022) | ||
15-43874319-C-T | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
15-43874320-A-G | Benign (May 16, 2018) | |||
15-43874432-G-A | Inborn genetic diseases | Uncertain significance (Oct 04, 2022) | ||
15-43874457-C-G | Inborn genetic diseases | Uncertain significance (Jan 06, 2023) | ||
15-43883748-C-T | Inborn genetic diseases | Uncertain significance (Jun 18, 2021) | ||
15-43883758-C-G | Inborn genetic diseases | Uncertain significance (Jun 09, 2022) | ||
15-43883765-C-T | Neurodevelopmental disorder with eye movement abnormalities and ataxia | Uncertain significance (-) | ||
15-43883778-A-G | Neurodevelopmental disorder with eye movement abnormalities and ataxia | Pathogenic (Oct 27, 2022) | ||
15-43883784-A-G | See cases • Neurodevelopmental disorder with eye movement abnormalities and ataxia | Uncertain significance (Aug 19, 2022) | ||
15-43883785-G-C | See cases • Neurodevelopmental disorder with eye movement abnormalities and ataxia | Uncertain significance (Aug 19, 2022) | ||
15-43883786-C-T | Neurodevelopmental disorder with eye movement abnormalities and ataxia | Likely pathogenic (May 09, 2023) | ||
15-43883787-T-C | Neurodevelopmental disorder with eye movement abnormalities and ataxia | Pathogenic (Oct 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FRMD5 | protein_coding | protein_coding | ENST00000417257 | 14 | 324489 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00276 | 125739 | 0 | 7 | 125746 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.98 | 221 | 321 | 0.689 | 0.0000180 | 3722 |
Missense in Polyphen | 83 | 134.02 | 0.61931 | 1553 | ||
Synonymous | -0.313 | 123 | 119 | 1.04 | 0.00000635 | 1100 |
Loss of Function | 4.62 | 3 | 30.5 | 0.0983 | 0.00000163 | 361 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in regulation of cell migration (PubMed:22846708, PubMed:25448675). May regulate cell-matrix interactions via its interaction with ITGB5 and modifying ITGB5 cytoplasmic tail interactions such as with FERMT2 and TLN1. May regulate ROCK1 kinase activity possibly involved in regulation of actin stress fiber formation (PubMed:25448675).;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.242
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.36
Haploinsufficiency Scores
- pHI
- 0.497
- hipred
- Y
- hipred_score
- 0.754
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.665
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Frmd5
- Phenotype
- skeleton phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of cell migration;actomyosin structure organization;positive regulation of cell adhesion;negative regulation of cell motility
- Cellular component
- cytoskeleton;adherens junction;integral component of membrane
- Molecular function
- integrin binding;protein binding;cytoskeletal protein binding;protein kinase binding